• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND RESOLUTE ONYX RX; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND RESOLUTE ONYX RX; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Catalog Number RONYX30026JX
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Thrombus (2101); Rupture (2208); Injury (2348)
Event Date 07/11/2019
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
A resolute onyx rx coronary drug eluting stent was used to treat a mildly tortuous, mildly calcified lesion in the left anterior descending (lad) artery.There was no damaged noted to the packaging.There were no issues removing the device from the hoop.The device was inspected with no issues.Negative prep was performed with no issues noted.Pre dilation was performed for the target lesion.The device did not pass through a previously deployed stent.Resistance was not encountered when advancing the device.Excessive force was not used during the delivery.The device was implanted with no issues and the procedure completed.The following day, the patient suffered sub acute (>24 hours-30 days) stent thrombosis.An emergency poba procedure was performed using a balloon to inflate within the stent to restore blood flow.The procedure was completed.
 
Manufacturer Narrative
Additional information: it was stated that although the stent was fully expanded there seemed to be a slight plaque leak.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Additional information: prior to the procedure, the patient had a slight fever of 37 degrees, and crp was a little high at 8.0.The patient was put on dapt four days prior to the pci procedure.One month after pci was performed, the patient was discharged from the hospital if information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESOLUTE ONYX RX
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8841203
MDR Text Key152637054
Report Number9612164-2019-03117
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P160043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 10/22/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/30/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/25/2020
Device Catalogue NumberRONYX30026JX
Device Lot Number0009206929
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/15/2019
Date Device Manufactured06/26/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age73 YR
Patient Weight50
-
-